Ducon Infratechnologies board to meet on June 12 to consider rights issue
Ducon Infratechnologies Limited will hold a board meeting on June 12, 2026, to consider a rights issue of equity shares to raise funds. The trading window for designated persons will close from June 12 until 48 hours after the meeting concludes.

*this image is generated using AI for illustrative purposes only.
Ducon Infratechnologies Limited has scheduled a board meeting for June 12, 2026, to consider a proposal for raising funds through a rights issue of equity shares. The meeting will be held via video conferencing at 5:30 P.M., with the registered office in Thane serving as the deemed venue. The primary agenda item is the issuance of equity shares on a rights basis to secure capital.
The board will also address any other business matters with the permission of the chairperson. This initiative follows Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
In conjunction with the meeting, the company has announced the closure of the trading window for all designated persons and their immediate relatives. This restriction is effective from June 12, 2026, and will remain in place until 48 hours after the conclusion of the board meeting. The measure is in accordance with Clause 4 of Schedule B of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company’s internal Code of Conduct for Prevention of Insider Trading.
| Agenda Item | Details |
|---|---|
| Meeting Date | June 12, 2026 |
| Meeting Time | 05:30 P.M. |
| Mode | Video Conferencing |
| Proposal | Rights issue of equity shares |
| Trading Window Closure | June 12, 2026, until 48 hours post-meeting |
Historical Stock Returns for Ducon Infratechnologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.80% | -2.24% | +2.95% | -3.86% | -43.98% | -64.28% |
What specific capital allocation plans does Ducon Infratechnologies intend to fund with the proceeds from the proposed rights issue?
How will the rights issue ratio and pricing be determined, and what impact could this have on existing shareholder dilution?
What is the expected timeline for the regulatory approval process and the subsequent launch of the rights issue?


































